# First Northwest Bancorp: financial statements, quarterly

FNWB · Nasdaq · CIK 1556727 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fnwb.md) · [Financials](/companies/fnwb/financials.md) · [Filings](/companies/fnwb/filings.md) · [Insiders](/companies/fnwb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fnwb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [10.9](/filings/0001437749-23-031577.md) | [12.1 d](/filings/0001437749-24-008142.md) | [13.4](/filings/0001437749-24-016267.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.6](/filings/0001437749-24-034591.md) | [(1.4) d](/filings/0001437749-25-007492.md) | [0.4](/filings/0001437749-25-016126.md) | [(0.5)](/filings/0001437749-25-025349.md) | [(1.2)](/filings/0001437749-25-033588.md) | [0.4 d](/filings/0001437749-26-008021.md) | [(1.1)](/filings/0001437749-26-015523.md) | [0.3](/filings/0001437749-26-026287.md) | [(0.9)](/filings/0001437749-25-033588.md) | [0.5 d](/filings/0001437749-26-008021.md) | [(0.3)](/filings/0001437749-26-015523.md) | [0.0](/filings/0001437749-26-026287.md) |
| Net income | $m | [2.5](/filings/0001437749-24-034591.md) | [(5.5) d](/filings/0001437749-25-007492.md) | [0.4](/filings/0001437749-24-016267.md) | [(2.2)](/filings/0001437749-24-032158.md) | [(2.0)](/filings/0001437749-24-034591.md) | [(2.8) d](/filings/0001437749-26-008021.md) | [(9.0)](/filings/0001437749-26-015523.md) | [3.7](/filings/0001437749-26-026287.md) | [0.8](/filings/0001437749-25-033588.md) | [0.4 d](/filings/0001437749-26-008021.md) | [0.0](/filings/0001437749-26-015523.md) | [0.3](/filings/0001437749-26-026287.md) |
| Diluted EPS | $ per share | [0.28](/filings/0001437749-24-034591.md) | not reported | [0.04](/filings/0001437749-25-016126.md) | [(0.25)](/filings/0001437749-25-025349.md) | [(0.23)](/filings/0001437749-25-033588.md) | not reported | [(1.03)](/filings/0001437749-26-015523.md) | [0.42](/filings/0001437749-26-026287.md) | [0.09](/filings/0001437749-25-033588.md) | not reported | [0.00](/filings/0001437749-26-015523.md) | [0.03](/filings/0001437749-26-026287.md) |
| Basic EPS | $ per share | [0.28](/filings/0001437749-24-034591.md) | not reported | [0.04](/filings/0001437749-25-016126.md) | [(0.25)](/filings/0001437749-25-025349.md) | [(0.23)](/filings/0001437749-25-033588.md) | not reported | [(1.03)](/filings/0001437749-26-015523.md) | [0.42](/filings/0001437749-26-026287.md) | [0.09](/filings/0001437749-25-033588.md) | not reported | [0.00](/filings/0001437749-26-015523.md) | [0.03](/filings/0001437749-26-026287.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,154](/filings/0001437749-23-031577.md) | [2,202](/filings/0001437749-25-007492.md) | [2,240](/filings/0001437749-24-016267.md) | [2,216](/filings/0001437749-24-032158.md) | [2,255](/filings/0001437749-24-034591.md) | [2,232](/filings/0001437749-26-008021.md) | [2,171](/filings/0001437749-25-016126.md) | [2,195](/filings/0001437749-25-025349.md) | [2,111](/filings/0001437749-25-033588.md) | [2,108](/filings/0001437749-26-026287.md) | [2,133](/filings/0001437749-26-015523.md) | [2,125](/filings/0001437749-26-026287.md) |
| Total liabilities | $m | [1,997](/filings/0001437749-23-031577.md) | [2,038](/filings/0001437749-25-007492.md) | [2,080](/filings/0001437749-24-016267.md) | [2,057](/filings/0001437749-24-032158.md) | [2,095](/filings/0001437749-24-034591.md) | [2,078](/filings/0001437749-26-008021.md) | [2,025](/filings/0001437749-25-016126.md) | [2,046](/filings/0001437749-25-025349.md) | [1,957](/filings/0001437749-25-033588.md) | [1,951](/filings/0001437749-26-026287.md) | [1,976](/filings/0001437749-26-015523.md) | [1,967](/filings/0001437749-26-026287.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [156](/filings/0001437749-23-031577.md) | [163](/filings/0001437749-24-008142.md) | [161](/filings/0001437749-25-025349.md) | [159](/filings/0001437749-24-032158.md) | [161](/filings/0001437749-25-033588.md) | [154](/filings/0001437749-26-026287.md) | [146](/filings/0001437749-26-026287.md) | [150](/filings/0001437749-26-026287.md) | [155](/filings/0001437749-25-033588.md) | [157](/filings/0001437749-26-026287.md) | [157](/filings/0001437749-26-026287.md) | [158](/filings/0001437749-26-026287.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.5) d](/filings/0001437749-24-034591.md) | [2.6 d](/filings/0001437749-25-007492.md) | [(4.9)](/filings/0001437749-25-016126.md) | [8.1 d](/filings/0001437749-25-025349.md) | [1.2 d](/filings/0001437749-25-033588.md) | [12.5 d](/filings/0001437749-26-008021.md) | [(21.7)](/filings/0001437749-26-015523.md) | [4.0 d](/filings/0001437749-26-026287.md) | [4.7 d](/filings/0001437749-25-033588.md) | [10.3 d](/filings/0001437749-26-008021.md) | [0.9](/filings/0001437749-26-015523.md) | [1.5 d](/filings/0001437749-26-026287.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001437749-23-031577.md) | [0.5 d](/filings/0001437749-24-008142.md) | [0.1](/filings/0001437749-24-016267.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [0.7 d](/filings/0001437749-24-034591.md) | [0.7 d](/filings/0001437749-25-007492.md) | [0.7](/filings/0001437749-25-016126.md) | [0.7 d](/filings/0001437749-25-025349.md) | [0.7 d](/filings/0001437749-25-033588.md) | [0.7 d](/filings/0001437749-26-008021.md) | [0.6](/filings/0001437749-26-015523.md) | [0.7 d](/filings/0001437749-26-026287.md) | [0.0 d](/filings/0001437749-25-033588.md) | [0.0 d](/filings/0001437749-26-008021.md) | [0.0](/filings/0001437749-26-015523.md) | [0.0 d](/filings/0001437749-26-026287.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-034591.md) | [0.2 d](/filings/0001437749-25-007492.md) | [3.0](/filings/0001437749-25-016126.md) | [0.0 d](/filings/0001437749-25-025349.md) | [1.0 d](/filings/0001437749-25-033588.md) | [0.0 d](/filings/0001437749-26-008021.md) | [0.0](/filings/0001437749-25-016126.md) | [0.0 d](/filings/0001437749-25-025349.md) | [0.0 d](/filings/0001437749-25-033588.md) | [0.0 d](/filings/0001437749-26-008021.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [9,138](/filings/0001437749-23-031577.md) | [8,940](/filings/0001437749-24-016267.md) | [8,931](/filings/0001437749-24-032158.md) | [8,935](/filings/0001437749-24-034591.md) | [8,907](/filings/0001437749-25-016126.md) | [8,783](/filings/0001437749-25-025349.md) | [8,757](/filings/0001437749-25-033588.md) | [8,747](/filings/0001437749-26-015523.md) | [8,791](/filings/0001437749-26-026287.md) | [8,814](/filings/0001437749-25-033588.md) | [8,895](/filings/0001437749-26-015523.md) | [8,931](/filings/0001437749-26-026287.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,511,615 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026287.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.